High grade astrocytic tumor
MONDO:0016680An anaplastic astrocytoma (grade III astrocytic tumor) or glioblastoma (grade IV astrocytic tumor).
Also known as: high grade astrocytic neoplasm, high grade astrocytic tumor, high-grade astrocytic neoplasm, high-grade astrocytic tumor, high-grade astrocytic tumour, high-grade astrocytoma
3433 clinical trials for this condition and its sub-types, 8 tagged with High grade astrocytic tumor itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of High grade astrocytic tumor
-
Glioblastoma 638 trials · 651 incl. sub-types
7 sub-types
- Brain glioblastoma 24 trials · 87 incl. sub-types Sub-types →
- IDH-wildtype glioblastoma 83 trials
- Adult glioblastoma 25 trials Sub-types →
- Classical glioblastoma 3 trials
- Mesenchymal glioblastoma 0 trials
- Neural glioblastoma 0 trials
- Proneural glioblastoma 0 trials
-
Anaplastic astrocytoma 53 trials · 101 incl. sub-types
3 sub-types
- IDH-mutant anaplastic astrocytoma 10 trials · 49 incl. sub-types Sub-types →
- IDH-wildtype anaplastic astrocytoma 3 trials
- High-grade astrocytoma with piloid features 0 trials
-
Gliomatosis cerebri 1 trial
Most studied deeper sub-types
-
New drug combo aims to boost immune attack on returning brain tumors
Disease control Recruiting nowThis study tests two immunotherapy drugs, efineptakin alfa and pembrolizumab, in people whose glioblastoma (a type of brain cancer) has returned after standard treatment. The goal is to see if this combination can help the immune system fight the tumor and improve survival. About…
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Brain tumor patients get Virus-Radiation combo in early trial
Disease control Recruiting nowThis early-phase trial tests a new approach for people with recurrent high-grade astrocytomas, a type of aggressive brain cancer. During surgery to remove the tumor, doctors inject a modified virus directly into the brain cavity, followed by targeted radiation. The main goal is t…
Phase 1 • Sponsor: Henry Ford Health System • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Brain tumor samples used to tailor drug cocktails in recurrent glioma trial
Knowledge-focused Recruiting nowThis study tests a new way to choose drug combinations for people with recurrent high-grade astrocytic glioma, a type of aggressive brain cancer. Researchers take a sample of the tumor, grow it in the lab, and test many drug combinations to find the best one for that patient. The…
Sponsor: National University Hospital, Singapore • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC